These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10719944)

  • 21. Oral transmucosal fentanyl citrate (lollipop) premedication in human volunteers.
    Stanley TH; Hague B; Mock DL; Streisand JB; Bubbers S; Dzelzkalns RR; Bailey PL; Pace NL; East KA; Ashburn MA
    Anesth Analg; 1989 Jul; 69(1):21-7. PubMed ID: 2742164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
    Shaiova L; Lapin J; Manco LS; Shasha D; Hu K; Harrison L; Portenoy RK
    Support Care Cancer; 2004 Apr; 12(4):268-73. PubMed ID: 14750002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.
    Aronoff GM; Brennan MJ; Pritchard DD; Ginsberg B
    Pain Med; 2005; 6(4):305-14. PubMed ID: 16083461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Mangione S; Intravaia G
    Br J Cancer; 2007 Jun; 96(12):1828-33. PubMed ID: 17519902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Modulated Electrohyperthermia on the Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers.
    Lee SY; Kim MG
    Clin Ther; 2016 Dec; 38(12):2548-2554. PubMed ID: 27866658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield.
    Wedmore IS; Kotwal RS; McManus JG; Pennardt A; Talbot TS; Fowler M; McGhee L
    J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S490-5. PubMed ID: 23192075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.
    Payne R; Coluzzi P; Hart L; Simmonds M; Lyss A; Rauck R; Berris R; Busch MA; Nordbrook E; Loseth DB; Portenoy RK
    J Pain Symptom Manage; 2001 Jul; 22(1):575-83. PubMed ID: 11516599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
    Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
    J Opioid Manag; 2005; 1(1):36-40. PubMed ID: 17315410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danish pain specialists' rationales behind the choice of fentanyl transdermal patches and oral transmucosal systems--a delphi study.
    Jacobsen R; Møldrup C; Christrup L
    Pain Med; 2009 Nov; 10(8):1442-51. PubMed ID: 19793344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study.
    Hanks GW; Nugent M; Higgs CM; Busch MA;
    Palliat Med; 2004 Dec; 18(8):698-704. PubMed ID: 15623166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials.
    Hagen NA; Fisher K; Victorino C; Farrar JT
    J Palliat Med; 2007 Feb; 10(1):47-55. PubMed ID: 17298253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients.
    Mercadante S
    Expert Opin Pharmacother; 2012 Apr; 13(6):873-8. PubMed ID: 22424558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
    Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
    Clin Pharmacokinet; 2006; 45(8):843-50. PubMed ID: 16884321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral transmucosal fentanyl citrate versus placebo for painful dressing changes: a crossover trial.
    MacIntyre PA; Margetts L; Larsen D; Barker L
    J Wound Care; 2007 Mar; 16(3):118-21. PubMed ID: 17385588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
    Gordon DB
    Oncol Nurs Forum; 2006 Nov; 33(2):257-64. PubMed ID: 16518441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose pharmacokinetics of fentanyl buccal soluble film.
    Vasisht N; Gever LN; Tagarro I; Finn AL
    Pain Med; 2010 Jul; 11(7):1017-23. PubMed ID: 20492573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis.
    Jandhyala R; Fullarton J
    BMJ Support Palliat Care; 2012 Jun; 2(2):156-62. PubMed ID: 24654058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate.
    Kharasch ED; Hoffer C; Whittington D
    Anesthesiology; 2004 Sep; 101(3):738-43. PubMed ID: 15329599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children.
    Epstein RH; Mendel HG; Witkowski TA; Waters R; Guarniari KM; Marr AT; Lessin JB
    Anesth Analg; 1996 Dec; 83(6):1200-5. PubMed ID: 8942586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.